Christopher A. Hubbard

Devax, Inc. is a private, emerging medical device company developing a proprietary bifurcated stent system that is intended to provide a clinical solution to treat atherosclerotic disease in coronary bifurcations and left main coronary arteries. Coronary artery disease continues to be the number one cause of death in the United States and Europe. The Company believes there is significant potential for its unique stent system to serve as a platform technology to address and provide tailored care for bifurcations wherever they occur including those found in carotid and peripheral vascular disease. Devax is headquartered in Lake Forest, California.

Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA.

Epicor Medical, Inc. develops technologies to treat patients with atrial fibrillation. It is currently pursuing clinical evaluation of its High Intensity Focused Ultrasound (HIFU) ablation system for epicardial treatment of atrial fibrillation. The company was founded in 1999 and is located in Sunnyvale, CA.

Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA.

Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN.